Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, Estelle Vilain, Gillian Divard, Carole Burger, Alexandra Serris, Rébecca Sberro‐Soussan, Frank Martinez, Lucile Amrouche, Lynda Bererhi, Fanny Lanternier, Christophe Legendre, Julien Zuber, Dany Anglicheau, Anne Scemla
Topics & Concepts
BelataceptMedicineImmunogenicityVaccinationTiterAntibody titerAbataceptAntibodyKidney transplantationImmunologyInternal medicineKidney transplantKidneyRituximabSARS-CoV-2 and COVID-19 ResearchComplement system in diseasesHeparin-Induced Thrombocytopenia and Thrombosis